Johnson & Johnson Single-Dose Shot 66% Effective In Preventing COVID-19, Less Than Some Others
Video Credit: WJZ Baltimore - Duration: 00:30s - Published
Johnson & Johnson Single-Dose Shot 66% Effective In Preventing COVID-19, Less Than Some Others
Johnson & Johnson's long-awaited vaccine appears to protect against COVID-19 with just one shot β not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses.
Johnson and Johnson says its single-shot vaccine provides strong protection against severe cases of COVID-19, but it is somewhat less effective overall than the two mRNA vaccines currently in use.
Credit: ABC 10 News | San Diego Duration: 03:24Published
Johnson & Johnson says its single-shot COVID-19 vaccine is effective in preventing severe cases of COVID-19, but not as well as other two-shot variants of the vaccine that are already on the market.
![Johnson & Johnson's COVID-19 Vaccine Still Has Advantages Despite Less Effectiveness [Video]](https://video.newsserve.net/300/v/20210130/2101300427-Johnson-Johnson-COVID-19-Vaccine-Still.jpg)
![In-depth: New data on Johnson & Johnson COVID-19 vaccine [Video]](https://video.newsserve.net/300/v/20210130/2101300149-In-depth-New-data-on-Johnson-Johnson.jpg)
![Johnson & Johnson's single-shot vaccine proves effective in trial, but less so than Moderna, Pfizer [Video]](https://video.newsserve.net/300/v/20210129/2101292227-Johnson-Johnson-single-shot-vaccine-proves.jpg)
